Details

Autor(en) / Beteiligte

• Suárez-Rivero, Juan M.
• Pastor-Maldonado, Carmen J.
• de la Mata, Mario
• Villanueva-Paz, Marina
• Povea-Cabello, Suleva
• Álvarez-Córdoba, Mónica
• Villalón-García, Irene
• Suárez-Carrillo, Alejandra
• Talaverón-Rey, Marta
• Munuera, Manuel
• Sánchez-Alcázar, José A.

Titel

Atherosclerosis and Coenzyme Q10

Ist Teil von

• International journal of molecular sciences, 2019-10, Vol.20 (20), p.5195

Ort / Verlag

Basel: MDPI AG

Erscheinungsjahr

2019

Link zum Volltext

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• Atherosclerosis is the most common cause of cardiac deaths worldwide. Classically, atherosclerosis has been explained as a simple arterial lipid deposition with concomitant loss of vascular elasticity. Eventually, this condition can lead to consequent blood flow reduction through the affected vessel. However, numerous studies have demonstrated that more factors than lipid accumulation are involved in arterial damage at the cellular level, such as inflammation, autophagy impairment, mitochondrial dysfunction, and/or free-radical overproduction. In order to consider the correction of all of these pathological changes, new approaches in atherosclerosis treatment are necessary. Ubiquinone or coenzyme Q10 is a multifunctional molecule that could theoretically revert most of the cellular alterations found in atherosclerosis, such as cholesterol biosynthesis dysregulation, impaired autophagy flux and mitochondrial dysfunction thanks to its redox and signaling properties. In this review, we will show the latest advances in the knowledge of the relationships between coenzyme Q10 and atherosclerosis. In addition, as atherosclerosis phenotype is closely related to aging, it is reasonable to believe that coenzyme Q10 supplementation could be beneficial for both conditions.